Embed Size (px)
Citation preview
1
Name: Roi Treister Date: Thursday, November 1, 2018
CURRICULUM VITAE
1. Personal Details
Permanent Home Address: Moshav Regba, D.N. Western Galili, Israel
Home Telephone Number: 972-49529279
Office Telephone Number: 972-4614-6206
Cellular Phone: 972-53-383-9935
Email Address: [email protected]
2. Higher Education
a. Undergraduate and Graduate Studies
Degree Name of Institution
and Department
Period of Study
B.A Psychology, University of
Haifa
2003-2006
M.Sc The Rappaport Faculty of
Medicine, Technion
2006-2009
Ph.D The Rappaport Faculty of
Medicine, Technion
2009-2011
b. Post-Doctoral Studies
Name of Host Name of Institution and
Department/Lab
Period of Study
Professor Pud Dorit
Faculty of Social Welfare &
Health Sciences, University of
Haifa / The human
experimental pain lab
2011-2013
Professor Oaklander
Anne Louise
Neurology department,
Masseuses General Hospital &
Harvard University
2013-2016
2
3. Academic Ranks and Tenure in Institutes of Higher Education
Rank/Position Name of Institution and
Department
Years
Senior Lecturer The Cheryl Spencer
Department of Nursing,
University of Haifa
2016-present
4. Offices in Academic Administration
Role Name of Institution and
Department
Years
Referee at the faculty
ethical committee
The Cheryl Spencer
Department of Nursing,
University of Haifa
2017-present
Academic advisor for
the department BA
program
The Cheryl Spencer
Department of Nursing,
University of Haifa
2018-present
5. Scholarly Positions and Activities outside the University
Memberships in Academic Professional Associations Years
Israel Society for Neuroscience 2006–2013
Israel Pain Association 2007–present
The European Federation of IASP® Chapters 2007–present
International Association for the Study of Pain 2008–present
American Pain Society 2013–present
Participating in consensus meetings Years
Consensus meeting on “Non-Invasive Brain Stimulation –
challenges and directions for Pain studies
Radcliffe institute for advanced study, Harvard University,
Boson, MA
2013
ACTTION-CONCEPPT meeting on Small Fiber
Polyneuropathy
Washington, DC
2018
Consensus meeting on Small-fiber Polyneuropathy:
Preparing for Multi-Site Clinical Trials
Radcliffe institute for advanced study, Harvard University,
Boson, MA
2018
Reviewing for Refereed Journal Years
The Clinical Journal of Pain
IF 2017= 3.209
R 2017= Anesthesiology: 11/31 (Q2); Clinical Neurology:
69/197 (Q2)
2013-present
The Journal of Pain 2013-present
3
IF 2017= 4.859
R 2017= Clinical Neurology: 27/197 (Q1); Neurosciences:
51/261 (Q1)
Journal of Pain and Symptom Management
IF 2017= 3.249
R 2017= Health Care Sciences & Services: 18/94 (Q1);
Medicine, General & Internal: 29/155 (Q1); Clinical
Neurology: 67/197 (Q2)
2013-present
Experimental Brain Research
IF 2017= 1.806
R 2017= Neurosciences: 211/261 (Q4)
2013-present
European Journal of Neuroscience
IF 2017= 2.832
R 2017= Neurosciences: 143/261 (Q3)
2013-present
Neuromodulation: Technology at the Neural Interface
IF 2017= 2.774
R 2017= Medicine, Research & Experimental: 66/133(Q2)
Clinical Neurology: 92/197 (Q2)
2014-present
Pain Practice
IF 2017= 2.187
R 2017= Anesthesiology: 21/31 (Q3); Clinical Neurology:
119/197 (Q3)
2015-present
Pain Medicine
IF 2017= 2.782
R 2017= Anesthesiology: 13/31 (Q2); Medicine, General
& Internal: 35/155 (Q1)
2015-present
PLOS ONE
IF 2017= 2.766
R 2017= Multidisciplinary Sciences: 15/64 (Q1)
2015-present
Neuroscience letters
IF 2017= 2.159
R 2017= Neurosciences: 188/261 (Q3)
2015-present
European Child & Adolescent Psychiatry
IF 2017= 3.553
R 2017= Pediatrics: 9/124 (Q1); Psychiatry (SCIE): 43/142
(Q2); Psychology, Developmental: 13/73 (Q1); Psychiatry
(SSCI): 32/142 (Q1)
2015-present
Pain
IF 2017= 5.559
R 2017= Anesthesiology: 3/31 (Q1); Clinical Neurology:
21/197 (Q1); Neurosciences: 35/261 (Q1)
2016-present
Canadian Journal of Pain
(IF= N/A)
2017-present
Psychiatry Research
IF 2017= 2.223
R 2017= Psychiatry (SCIE): 77/142 (Q3); Psychiatry
(SSCI): 61/142 (Q2)
2017-present
British Journal of Psychology
IF 2017= 2.507
R 2017= Psychology, Multidisciplinary: 28/135 (Q1)
2017-present
4
Clinical Autonomic Research
IF 2017= 1.635
R 2017= Clinical Neurology: 157/197 (Q4);
Neurosciences: 220/261 (Q4)
2017-present
F1000Research
IF=N/A
2017-present
Clinical Neurology and Neurosurgery
IF 2017= 1.736
R 2017= Clinical Neurology: 151/197 (Q4); Surgery:
105/200 (Q3)
2017-present
Neurology
IF 2017= 8.055
R 2017= Clinical Neurology: 13/197 (Q1)
2017-present
Journal of Psychosomatic Research
IF 2017= 2.947
R 2017= Psychiatry (SCIE): 53/142 (Q2); Psychiatry
(SSCI): 41/142 (Q2)
2017-present
Seminars in Arthritis and Rheumatism
IF 2017= 4.356
R 2017= Rheumatology: 6/30 (Q1)
2017-present
Reviewing for Fund Agencies Years
Evaluation of research grant applications to the Novo
Nordisk Foundation (NNF), Denmark.
2015-2016
Evaluation of research grant applications to the
Department of Veterans Affairs, Spinal Cord Injury and
Neuropathic Pain panel.
2015-2016
6. Active Participation in Scholarly Conferences a1. International Conferences - Held Abroad
Role Subject of
Lecture/Discussion
Place of
Conference
Name of
Conference
Date
Poster Associations between
polymorphisms in dopamine
neurotransmitter pathway
genes and pain response in
healthy humans.
Lisbon,
Portugal
European
Federation of
International
Association
for the study
of Pain
Chapters
(EFIC), Pain
in Europe VI
2009
Poster (1) A bi-phasic effect of the
dopamine agonist apo-
morphine on the tolerance to
painful cold stimulation in
healthy subjects.
Hamburg,
Germany
European
Federation of
International
Association
for the study
2011
5
(2) A combination of
multiple autonomic
parameters, rather than each
parameter alone, yields
significant differentiation
between heat pain
intensities.
(3) Opioid induced
hyperalgesia – can it be
reversed? A study of active
and former opioid addicts
and drug naïve controls.
of Pain
Chapters
(EFIC), Pain
in Europe VII
Poster (1) Opioid-induced
analgesia and hyperalgesia
are reversely correlated: a
prospective study in patients
with neuropathic pain.
(2) Pharmacogenetic
evidence for the
involvement of dopamine in
pain processing.
(3) Effects of
methylphenidate on pain
processing.
(4) Attitudes and beliefs of
students upon meeting
patients suffering from
chronic pain.
Milano, Italy
IASP 14th
conference
2012
Poster Pilot study of the efficacy of
rTMS of primary motor
cortex for neuropathic itch
Boson, MA 7th World
Congress on
Itch (WCI)
2013
Poster (1)Pilot study of the effects
of rTMS on neuropathic
pain
(2) Pilot study of the
efficacy of rTMS of primary
motor cortex for neuropathic
itch.
Boson, MA Radcliffe
institute for
advanced
study,
Harvard
University
Consensus
meeting on
Non-Invasive
Brain
Stimulation
2013
Poster Objective Measurement of
Pain Levels in Patients with
Radicular Pain Treated by
Spinal Cord Stimulation
Phoenix, AZ American
Academy of
Pain
Management
(AAPM) 30th
2014
6
Annual
Meeting
Poster Spinal cord stimulation
attenuates temporal
summation in affected but
not in unaffected areas in
patients with neuropathic
pain
Buenos
Aires,
Argentina
15th World
Congress on
Pain
2014
Oral
presentation
Repetitive transcranial
magnetic stimulation
(rTMS) of the primary
motor cortex for treating
facial neuropathic pain –
preliminary results of a
randomized, sham-
controlled, cross-over study
Bethesda,
MD
The Seventh
TMJ
Association
Scientific
Meeting
2014
Poster Skin biopsy of normal
children demonstrates
inverse correlation between
age and epidermal nerve
fiber (ENF) density,
meaning age-specific norms
are needed
Baltimore,
MD.
The 139th
Annual
Meeting of
the American
Neurological
Association
2014
Poster (1) Repetitive transcranial
magnetic stimulation
(rTMS) of primary motor
cortex for neuropathic pain-
were to stimulate?; (2) First
assessment of intravenous
immunoglobulin (IVIG) for
treating chronic widespread
pain in small-fiber
polyneuropathy
Nice, France The 5th
International
Congress on
Neuropathic
Pain
(NeuPSIG
2015)
2015
Poster (1) Transcranial direct
current stimulation (tDCS)
for treating chronic pain –
preliminary results of open-
label, self-administered, at-
home treatment; (2)
Development of a screening
questionnaire for small-fiber
polyneuropathy (SFPN); (3)
First evaluation of efficacy
and safety of intravenous
immunoglobulin (IVIG)
treatment of dysimmune
small-fiber predominant
polyneuropathy (SFPN)
Santiago,
Chile.
The XXII
World
Congress of
Neurology
(WCN 2015)
2015
Poster The effect of dopamine
agonist (apomorphine) on
Vienna,
Austria
9th Congress
of the
2015
7
cold pain in patients with
chronic radicular pain
European
Pain
Federation
EFIC
Poster (1) First evaluation of
efficacy and safety of
immunoglobulin treatment
of dysimmune small-fiber
predominant
polyneuropathy (SFPN); (2)
Diagnostic Utility of Tests
for Medical Contributors to
Small-fiber Polyneuropathy
(SFPN)
Quebec
City, Canada
Peripheral
Nerve
Society
(PNS)
Annual
Meetings
2015
Poster (1) Cost/Benefit of Blood
Tests in Idiopathic Small-
fiber Polyneuropathy
(SFPN);
(2) First Evaluation of
Immunoglobulin (IVIG)
Treatment ofSmall-fiber
Axonal Polyneuropathy;
(3) Development of a
Comprehensive Symptom
Survey for Small-fiber
Polyneuropathy (SFPN)
Chicago, IL ANA 2015
Annual
Meeting
2015
Poster (1) Development and
Evaluation of an Accurate
Pain Reporting Training
Program; (2) Training
Subjects to Report Their
Pain More Accurately
Improves Study Power:
Results of a Randomized
Placebo-Controlled Study of
Pregabalin Versus Placebo
in Painful Diabetic
Neuropathy
Yokohama,
Japan
16th World
Congress on
Pain
2016
Poster (1) Implementation of a
Placebo Response
Reduction Training Program
in a Randomized
Controlled Trial in Chronic
Low Back Pain:
Comparison with Placebo
Responses in Published
Studies;
(2) Interventions to reduce
the placebo response in
clinical trials:
A systematic literature
Boston, MA 29th
Association
for
Psychological
Science
(APS)
Annual
Convention
2017
8
review
Poster Validation and continuing
development of a patient-
reported survey of small-
fiber polyneuropathy
(SFPN) symptoms
Boston, MA 69th
American
Academy of
Neurology
(AAN)
Annual
Meeting
2017
Poster (1) Implementation of the
Misuse, Abuse, and
Diversion Drug Event
Reporting System
(MADDERS®) to Evaluate
Potentially Abuse-Related
Events in Phase III Clinical
Trials of
a Sativex® Oromucosal
Spray for the Treatment of
Cancer-Related Pain;
(2) Placebo Response
Reduction Training Reduces
Placebo Responses in
Chronic Low Back Pain;
(3) Development,
Feasibility, and
Implementation of the
Misuse, Abuse, and
Diversion Drug Event
Reporting System
(MADDERS®) for
Assessing and Classifying
Misuse and Abuse-Related
Events in
Clinical Trials; (4) Accurate
Pain Reporting Training
Improved Subject Pain
Reporting and Treatment
Discrimination Performance
in a Randomized Placebo-
Controlled Study of
Pregabalin Versus Placebo
in Painful Diabetic
Neuropathy
Las-Vegas,
NV
PAINWeek
conference
2017
(1) Oral
Presentation
(2) Poster
(1) Pain literature research
trends in the new millennia
(2) accurate pain reporting
diminishes the placebo
response: results from a
randomized, double-blind,
crossover trial
Copenhagen,
Denmark
10th Congress
of the
European
Pain
Federation
EFIC
2017
Poster (1) Quantitative Sensory Boston, MA 17th World 2018
9
Testing before and after
Cordotomy: First case
series; (2) Pain reporting
accuracy and the placebo
response;
(3) Pain reporting accuracy
does not correlate with
ability to accurately
report other bodily
sensations
Congress on
Pain
Invited speaker Mitigating the placebo
response in clinical trials -
insights from recent studies
Vienna,
Austria
The
European
Congress on
Clinical
Trials in Pain
2018
a2. International Conferences - Held in Israel
Role Subject of Lecture/Discussion Place of
Conference
Name of
Conference
Date
None
a3. Local Conferences
Role Subject of
Lecture/Discussion
Place of
Conference
Name of
Conference
Date
Poster Factors affecting - and
relationships between -
different modes of
endogenous pain modulation
in healthy volunteers
Eilat The 17th,
annual
conference
of The Israeli
Society for
Neuroscience
2008
Oral
presentation
Associations between
polymorphisms in dopamine
neurotransmitter pathway
genes and pain response in
healthy humans
Ma'alot The annual
conference
of The Israeli
Pain
Association
2009
Oral
presentation
Measuring pain by statistical
processing of multiple non-
invasive physiological signals
Eilat The annual
conference
of the Israeli
Pain
Association
2010
Oral
presentation
Genetic evidence for the role
of dopamine pain and
analgesia
The Dead
Sea
The annual
conference
of the Israeli
Pain
Association
2011
Oral
presentation
Effects of methylphenidate on
pain processing
Eilat The annual
conference
of the Israeli
2012
10
Pain
Association
Invited
speaker
Pain assessment – a trait that
can be Improved?
Eilat The annual
conference
of the Israeli
Pain
Association
2017
Invited
speaker
Placebo effect - can research
findings be translated from
research to clinical care?
Caesarea Israeli
College of
Pain
Medicine
(ICPO)-6
2018
b. Organization of Conferences or Sessions
Role Subject of
Conference
Place of
Conference
Name of
Conference
Year
Organizer and
speaker
Pain reporting
accuracy
Boston, MA First meeting on
pain reporting
accuracy
2018
7. Invited Lectures (Others than in Scholarly Conferences)
Abroad
Role Subject of Lecture Place of
Lecture
Name of
Forum
Year
None
In Israel
Role Subject of Lecture Place of
Lecture
Name of
Forum
Year
Invited lecture Pain Assessment Tel-Aviv Medasense 2017
Invited lecture Pain Assessment Ness-Ziona MDbiosciences 2018
Invited lecture Small fiber
Polyneuropathy
Tel
Hashomer
Neurology
Department
2018
Invited lecture Pain Assessment Hebrew
Univ.
hadassah ein
kerem
Graduate course 2018
8. Colloquium Talks
Presentation
Place of Lecture Name of Forum Year
Oral presentation Massachusetts General
Hospitals
Pain rounds 2015
11
Invited speaker Athens, Greece Mitsubishi Pharma
Investigator Meeting: the
use of Quantitative
Sensory Testing in Painful
diabetic Neuropathy
2017
Invited speaker Boston, MA Harvard Radcliffe
workshop Small-fiber
Polyneuropathy: Preparing
for Multi-Site Clinical
Trials
2018
Invited speaker Barcelona, Spain Grunenthal Investigator
Meeting: the use of
Quantitative Sensory
Testing in Complex
Regional Pain Syndrome
2018
9. Research Grants
a. Grants Awarded
Years
Amount Funded by (C= Competitive Fund)
Title Other
Researchers (Name & Role)
Role in
Research
2009 2,500$ MANLAM,
Technion
Pain Genetics Dr. Eisenberg
Elon, PI
Co-PI
2012 10,000$
NIS
Israel Pain
Association
Effects of
methylphenidate
on pain
processing
Dr. Pud Dorit,
Co-PI
PI
2015 900,000 Gulf War
Illness
Research
Program
GW140169
(C)
Diagnosis of
late-stage, early-
onset, small-
fiber
polyneuropathy
Oaklander
Anne Louise,
PI.
Key
Personnel
2015 3,375,000$ NIH 1 R01
NS093653-
01A1
(C)
Evaluation of
small-fiber
polyneuropathy
as a cause of
chronic
widespread pain
in youth
Oaklander
Anne Louise,
PI.
Key
Personnel
2016-
2019
170,000
NIS
(the entire
amount in
my
Council for
Higher
Education,
Planning and
Budgeting
Alon
Fellowships for
Outstanding
Young
Researchers
None PI
12
account) Committee
(VATT)
(C)
2016-
2018
30,000€
(the entire
amount in
my
account)
EFIC
Grünenthal
Grant (E-G-
G)
(C)
Can training
increase
reporting
accuracy and
study power in
human pain
trials
None PI
2017 10,000
NIS
(Half of
the amount
in my
account)
FAPESP
(A treaty
between
University of
Haifa and São
Paulo
Research
Foundation)
(C)
Precision in
reporting pain,
taste, heartrate
and
psychometrics
among chronic
pain sufferer
groups and
healthy controls
Prof. Micha
Leshem, Co-PI
Co-PI
2018-
2021
1,080,000
NIS
(the entire
amount in
my
account)
Israel Science
Foundation
(ISF) (C)
A double-blind,
randomized
clinical trial to
assess the
effects of
carnosine on
neuropathic
pain in painful
diabetic
neuropathy
None PI
2018-
2020
1,900,000
NIS
(the entire
amount in
my
account)
Israel Science
Foundation
(ISF)
(C)
(half of the
funding from
ISF, the other
half matched
by the Univ)
Equipment
grant for new
faculty member
None PI
2018-
2020
20,000€
(half of the
amount in
my
account)
EANS: The
European
Association
of
Neurosurgical
Societies
(C)
Palliative
neurosurgical
procedures to
improve quality
of life care of
cancer patients
Dr. Ido Strauss,
Co-PI
Co-PI
2018-
2019
10,000
NIS
(half of the
amount in
my
Joint program
of the Faculty
of Medicine,
RAMBAM,
and
A pilot study to
investigate
cortical
mechanisms
underlying pain
Dr. Yelena
Granovsky, Co-
PI
Co-PI
13
account) University of
Haifa.
(C)
reporting
accuracy-
toward
improved pain
assessment
2018-
2019
50,000
NIS
(the entire
amount in
my
account)
Medasense
Ltd.
A study to
validate the
NOL measure
None PI
b. Submission of Research Proposals – Pending
Years Funded by (C= Competitive Fund)
Title Other Researchers (Name & Role)
Role in
Research
None
Not Funded –Submission of Research Proposals c.
Years Funded by (C= Competitive Fund)
Title Other Researchers (Name & Role)
Role in
Research
2017 Israeli Ministry of
Science,
Technology and
Space
(C)
A double-blind,
Randomized
clinical trial to
assess the
effects of
carnosine on
neuropathic
pain in painful
diabetic
neuropathy
None PI
2017 Israel Science
Foundation (ISF)
(C)
Exploring the
mechanisms by
which training
patients to more
accurately
report their pain
improves the
power of pain
studies
None PI
2017 Israel Science
Foundation (ISF)
(C)
Equipment
grant for new
faculty member
None PI
2017 Unites States-
Israel Binational
Science
Foundation (BSF)
(C)
Making it
Worse:
Development of
novel clinically
relevant
Gewandter Jennifer,
Co-PI
Co-PI
14
("achieved very
good score, but
not enough
funding")
evoked-pain
models for
chronic pain
2017 European
Reaserch Council
(ERC)- Starting
Grant
(C)
Can the
accuracy of
subjective
patient-reported
outcome
measures be
assessed and
improved? The
effects and
underlying
mechanisms of
training aimed
to improve pain
reporting
accuracy
None PI
2018 Israel Cancer
Research Fund
(ICRF)
(C)
Palliative
neurosurgical
procedures to
improve quality
of life care of
cancer patients
Ido Strauss, Co-PI Co-PI
2018 Technion-
University of
Haifa
collaborative
grant
(C)
Investigating
the mechanisms
underlying pain
reporting
accuracy –
toward
improved pain
assessment
Yelena Granovsky,
Co-PI
Co-PI
10. Scholarships, Awards and Prizes
2013 Haifa university award for excellent young investigators.
2014 Travel award grant, TMJ association.
2016 Alon Fellowships for Outstanding Young Researchers, by the Council for
Higher Education, Planning and Budgeting Committee (VATT) (170,000NIS)
2016 EGG award, EFIC Grunenthal Grant for young investigators (30,000€)
11. Teaching
a. Courses Taught in Recent Years
15
Number of
Students
Level
Type of Course Lecture/Seminar/
Workshop/ Online Course/ Introduction
Course (Mandatory)
Name of
Course
Years
50 BA Lecture Pain
mechanisms
and pain
management
2011-
2013
70 BA Statistics 2011-
2013
70 BA Lecture SPSS software 2011-
2013
120 BA Introduction course Chemistry &
Biochemistry
2016-
present
20 BA Workshop Interpersonal
skills
2016-
2017
30 MSc Graduate course Selected topics
in Drug
Development
2017-
present
120 BA Introduction course Statistics &
Research
methods
2018-
present
40 BA Workshop Research
Seminar
2018-
present
b. Supervision of Graduate Students
Students'
Achievements
Year of
Completion/
In Progress
Degree Title of Thesis Name of
Other
Mentors
Name of
Student /
M.A.
Students
In Progress M.Sc Would training
aimed to
improve pain-
reporting
accuracy affect
the placebo
response?
Anna
Zisberg
Ehab
Matta
In Progress M.Sc Does
transcranial
Direct Current
Stimulation
(tDCS)
improve the
effect of mirror
therapy? A
double-blind
Dorit Pud Nitza
Segal
16
randomized
controlled
study in
patients with
phantom limb
pain
In Progress M.Sc Challenges in
pediatric Pain
assessment
Dafna
Zontag
One
manuscript
under review,
a second
manuscript in
preparation
In Progress M.Sc
Relationships
between the
ability to
accurately
report pain and
accuracy
reporting of
other bodily
sensations
Rita
Canaipa
Mariana
Ribolhos
Agostinho
In Progress M.Sc
Relations
between pain
sensitivity,
pain
modulation,
and pain
reporting
accuracy
Rita
Canaipa
Amira Buz
Khallouf
Ph.D.
Students
2 manuscripts
published (#
23, 31)
2016 PhD Effects of
social rejection
on pain
Co-PI with
Alexandre
Castro Caldas
Alexandre
de Lemos
Castro
Caldas
Rita Isabel
Mangerico
Canaipa
In Progress PhD Mechanisms
Underlying
Variability and
Accuracy of
Pain Reports:
The role of
Interoception
and Psycho-
Cognitive
characteristics
Michal
Granot Shlomit
Ilan
Post
Doctorate
Students
None
12. Miscellaneous
17
None
PUBLICATIONS
ISI- Sum of time cited: 357
SCOPUS- Sum of time cited: 559; h-index=15; g index=23
Google Scholar- Sum of time cited: 595; h index=15, i10 index- 18
A. Ph.D. Dissertation Title: Genetic, psychophysical and pharmacological evidence for dopamine and
serotonin involvement in pain perception and modulation in healthy subjects.
Date of submission:
Number of pages:
Language: English
Name of supervisor: Prof. Dorit Pud and Prof. Elon Eisenberg.
University: Technion- Israel Institute of Thechnology
Publications: 1,2,3,9,10
Index:
I.F. = Impact Factor (Source & Year)
V = Vatat List (The Council for Higher Education) אין מדדים אחריםשלמקרים
R = Ranking (Source & Year)
Q = Quartile
# = Student
B. Scientific Books (Refereed)
Authored Books – Published
None
Authored Books - Accepted for Publication
None
Edited Books and Special Journal Issues - Published
None
Edited Books and Special Journal Issues - Accepted for Publication
None
C. Monographs
Published
None
18
Accepted for Publication
None
D. Articles in Refereed Journals
Published 1. Treister R, Pud D, Ebstein RP, Liba E, Gershon E, Haddad M, and Eisenberg E.
Associations between polymorphisms in dopamine neurotransmitter pathway
genes and pain response in healthy humans. Pain. 2009;147(1-3):187-193.
IF 2009= 5.371; R 2009= Anesthesiology: 1/25 (Q1); Clinical Neurology:
16/167 (Q1); Neurosciences: 34/231 (Q1)
2. Treister R, Eisenberg E, Gershon E, Haddad M, Pud D. Factors affecting and
relationships between - different modes of endogenous pain modulation in
healthy volunteers. European Journal of Pain. 2010;14(6):608-614.
IF 2010= 3.819; R 2010= Anesthesiology: 4/26 (Q1); Clinical Neurology:
34/185 (Q1); Neurosciences: 70/239 (Q2)
3. Treister R, Pud D, Ebstein RP, Laiba E, Gershon E, Haddad M, Eisenberg E.
Association between polymorphisms in serotonin and dopamine-related genes
and endogenous analgesia. Journal of Pain. 2011;12(8):875-883.
IF 2011= 4.926; R 2011= Clinical Neurology: 19/192 (Q1); Neurosciences:
44/244 (Q1)
4. Treister R, Kliger, M, Zuckerman, G, Goor Aryeh, I, Eisenberg, E.
Differentiating between heat pain intensities: The combined effect of multiple
autonomic parameters. Pain. 2012;153(9):1807-1814.
IF 2012= 5.644; R 2012= Anesthesiology: 1/30 (Q1); Clinical Neurology:
13/193 (Q1); Neurosciences: 31/252 (Q1)
5. Treister R, Pud D, Eisenberg E. Is opioid-induced hyperalgesia reversible? A
study on active and former opioid addicts and drug naïve controls. Journal of
Opioid Management. 2012;8(6):343-349.
IF=N/A; SJR 2012= 0.760; R 2012= Anesthesiology and Pain Medicine: 30/130
(Q1); Medicine (miscellaneous): 798/2941 (Q2); Pharmacology (medical):
85/265 (Q2)
6. Suzan E, Eisenberg E, Treister R, Haddad M, Pud D. A negative correlation
between hyperalgesia and analgesia in patients with chronic radicular pain: Is
19
hydromorphone therapy a double-edged sword? Pain Physician. 2013;16(1):65-
76.
IF 2013= 4.766; R 2013= Clinical Neurology: 24/194 (Q1)
7. Eisenberg E, Sandler I, Treister R, Suzan E, Haddad M. Anti tumor necrosis
factor - alpha adalimumab (Humira®) for complex regional pain syndrome type
1 (CRPS-I): A case series. Pain Practice. 2013;13(8):649-656.
IF 2013= 2.183; R 2013= Anesthesiology: 14/29 (Q2); Clinical Neurology:
97/194 (Q2)
8. Suzan E, Midbari A, Treister R ,Haddad M, Pud D, Eisenberg E. Oxycodone
alters Temporal Summation (TS) but not Conditioned Pain Modulation (CPM):
Preclinical findings and possible relations to mechanisms of opioid analgesia.
Pain. 2013;154(8):1413-1418.
IF 2013= 5.836; R 2013= Anesthesiology: 2/29 (Q1); Clinical Neurology:
12/194 (Q1); Neurosciences: 31/252 (Q1)
9. Treister R, Pud D, Eisenberg E. The Dopamine Agonist Apomorphine
Enhances Conditioned Pain Modulation in Healthy Humans. Neuroscience
Letters. 2013;548:115-119.
IF 2013= 2.055; R 2013= Neurosciences: 178/252 (Q3)
10. Treister R, Pud D, Ebstein RP, Eisenberg E. Dopamine transporter genotype
dependent effects of apomorphine on cold pain tolerance in healthy volunteers.
PLoS One. 2013;8(5):e63808.
IF 2013= 3.534; R 2013= Multidisciplinary Sciences: 8/55 (Q1)
11. Treister R, Lang M, Klein MM, Oaklander AL. Non-invasive Transcranial
Magnetic Stimulation (TMS) of the Motor Cortex for Neuropathic Pain—At the
Tipping Point? Rambam Maimonides Medical Journal. 2013;4(4):e0023.
IF= N/A
12. Pud D, Treister R, Eisenberg E. Sub-grouping healthy subject’s sensitivity to
pain and its relationship to personality traits: Results of a cluster analysis.
Journal of Applied Mathematics. 2014;5(11), 1705-1712.
IF= N/A
13. Treister R, Eisenberg E, Demeter N, Pud D. Alterations in Pain Response are
Partially Reversed by Methylphenidate (Ritalin) in Adults with Attention Deficit
Hyperactivity Disorder (ADHD). Pain Practice. 2015;15(1):4-11.
20
IF 2015= 2.317; R 2015= Anesthesiology: 12/31 (Q2); Clinical Neurology:
97/193 (Q3)
14. Suzan E, Treister R, Haddad M, Pud D, Eisenberg E. "The effect of
hydromorphone therapy on psychophysical measurements of the descending
inhibitory pain systems in patients with chronic radicular pain". Pain Medicine.
2015;16(1):168-175.
IF 2015= 2.324; R 2015= Medicine, General & Internal: 36/155 (Q1)
15. Eisenberg E, Burstein Y, Suzan E, Treister R, Aviram J. Spinal cord
stimulation attenuates temporal summation in patients with neuropathic pain.
Pain. 2015;156(3):381-385.
IF 2015= 5.557; R 2015= Anesthesiology: 2/31 (Q1); Clinical Neurology:
17/193 (Q1); Neurosciences: 30/256 (Q1)
16. Goldstein L, Ariche K, Eisenberg E, Treister R, Geller R. Lumbar Facet Joint
Injections: Is CT Guided Intra-Articular Needle Position Advantageous? Journal
of Pain & Relief. 2015;4(2):1-6.
IF= N/A
17. Suzan E, Aviram J, Treister R, Eisenberg E ,Pud D. Individually-based
measurement of temporal summation evoked by a noxious tonic heat Paradigm.
The Journal of Pain Research. 2015;16(8):409-415.
IF 2015= 2.363; R 2015= Clinical Neurology: 94/193 (Q2)
18. Treister R, Nielsen CS, Stubhaug A, Farrar TJ, Pud D, Sawilowsky S,
Oaklander AL. Experimental comparison of parametric versus nonparametric
analyses of data from the cold pressor test. Journal of Pain. 2015;16(6):537-548.
IF 2015= 4.463; R 2015 = Clinical Neurology: 31/193 (Q1); Neurosciences:
56/256 (Q1)
19. Klein MM, Treister R, Raij T, Pascual-Leone A, Park L, Nurmikko T, Lenz F,
Lefaucheur JP, Lang M, Hallett M, Fox M, Costello A, Cudkowicz M, Carr DB,
Ayache SS, Oaklander AL. Transcranial Magnetic Stimulation (TMS) of the
Brain: Guidelines for Pain Treatment Research. Pain. 2015;156(9):1601-14.
IF 2015= 5.557; R 2015= Anesthesiology: 2/31 (Q1); Clinical Neurology:
17/193 (Q1); Neurosciences: 30/256 (Q1)
20. Treister R, O’Neil K, Downs H, Oaklander AL. Validation of the Composite
Autonomic Symptom Scale-31 (COMPASS-31) in Patients with Small-fiber
Polyneuropathy. European Journal of Neurology. 2015;22(7):1124-30.
21
IF 2015= 3.956; R 2015= Clinical Neurology: 38/193 (Q1); Neurosciences:
67/256 (Q2)
21. Gruss S, Treister R, Werner P, Traue HC, Crawcour S, Andrade A, Walter S.
Pain Intensity Recognition Rates via Biopotential Feature Patterns with Support
Vector Machines. PLoS One. 2015;16;10(10):e0140330.
IF 2015= 3.057; R 2015= Multidisciplinary Sciences: 11/63 (Q1)
22. Treister R, Nielsen CS, Stubhaug A, Farrar TJ, Pud D, Sawilowsky S,
Oaklander AL. Response to the Letter to the Editor: Experimental Comparison
of Parametric Versus Nonparametric Analyses of Data From the Cold Pressor
Test. The Journal of Pain. 2016;17(1):128-129.
IF 2016= 4.519; R 2016= Clinical Neurology: 31/194 (Q1); Neurosciences:
58/259 (Q1)
23. #Canaipa R, Treister R, Moreira JM, Caldas AC. Feeling hurt: Pain sensitivity
is correlated with and modulated by social distress. Clinical Journal of Pain.
2016;32(1):14-19.
IF 2016= 3.492; R 2016= Anesthesiology: 9/31 (Q2); Clinical Neurology:
54/194 (Q2)
24. Treister R, Trudeau JJ, Van Inwegen R, Jones JK, Katz NP. Development and
feasibility of the misuse, abuse, and diversion drug event reporting system
(MADDERS®). American. Journal on Addictions. 2016;25:641–651.
IF 2016= 1.873; R 2016= Substance Abuse: 19/34 (Q3)
25. Owoyele B V., Yakubu MT, Treister R. Pain and Inflammation: Update on
Emerging Phytotherapy, Zootherapy, and Nutritional Therapies. Evidence-based
Complementary and Alternative Medicine. 2016;2016:1.
IF 2016= 1.740; R 2016= Integrative & Complementary Medicine: 10/26 (Q2)
26. Klein MM, Treister R, Raij T, Pascual-Leone A, Park L, Nurmikko T, Lenz F,
Lefaucheur J-P, Lang M, Hallett M, Fox M, Costello A, Carr DB, Ayache SS,
Oaklander AL. Repetitive transcranial magnetic stimulation for pain: is it too
early to standardise repetitive transcranial magnetic stimulation protocols?
Reply. Pain. 2016;157(5):1175–1176.
IF 2016= 5.445; R 2016= Anesthesiology: 3/31 (Q1); Clinical Neurology:
20/194 (Q1); Neurosciences: 33/259 (Q1)
27. Lang M, Treister R, Oaklander AL. Diagnostic value of blood tests for occult
causes of initially idiopathic small-fiber polyneuropathy. Journal of Neurology.
22
2016;263(12):2515–2527.
IF 2016= 3.389; R 2016= Clinical Neurology: 59/194 (Q2)
28. Treister R, Nielsen CS, Stubhaug A, Farrar JT, Pud D, Sawilowsky S,
Oaklander AL. Response to the Letter to the Editor: Experimental Comparison
of Parametric Versus Nonparametric Analyses of Data From the Cold Pressor
Test. Journal of Pain. 2016;17(1):128-129.
IF 2016= 4.519; R 2016= Clinical Neurology: 31/194 (Q1); Neurosciences:
58/259 (Q1)
29. Liu X, Treister R, Yan Y, Wang H, Li X. Automated Mechanical Repositioning
Treatment for Posterior Canal Benign Paroxysmal Positional Vertigo: A Single-
Center Experience and Literature Review. European Neurology. 2017;78(5-
6):240–246.
IF 2017= 1.562; R 2017= Clinical Neurology: 160/197 (Q4); Neurosciences:
226/261 (Q4)
30. Mayorga AJ, Flores CM, Trudeau JJ, Moyer JA, Shalayda K, Dale M, Frustaci
ME, Katz N, Manitpisitkul P, Treister R, Ratcliffe S, Romano G. A randomized
study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist
mavatrep in patients with osteoarthritis. Scandinavian Journal of Pain.
2017;17:134–143.
IF=N/A; SJR 2017= 0.401; R 2017= Anesthesiology and Pain Medicine: 61/124
(Q2); Neurology (clinical): 231/359 (Q3)
31. #Canaipa R, Castro-Caldas A, Moreira JM, Pimentel-Santos F, Branco JC,
Treister R. Impaired Pain Modulation in Fibromyalgia Patients in Response to
Social Distress Manipulation. Clinical Journal of Pain 2017;33:611–619.
IF 2017= 3.209; R 2017= Anesthesiology: 11/31 (Q2); Clinical Neurology:
69/197 (Q2)
32. Treister R, Eaton TA, Trudeau JJ, Elder H, Katz NP. Development and
preliminary validation of the focused analgesia selection test to identify accurate
pain reporters. Journal of Pain Research. 2017;10:319–326.
IF 2017= 2.645; R 2017= Clinical Neurology: 99/197 (Q3)
33. Treister R, Lodahl M, Lang M, Tworoger SS, Sawilowsky S, Oaklander AL.
Initial Development and Validation of a Patient-Reported Symptom Survey for
Small-Fiber Polyneuropathy. Journal of Pain. 2017;18:556–563.
23
IF 2017= 4.859; R 2017= Clinical Neurology: 27/197 (Q1); Neurosciences:
51/261 (Q1)
34. Lodahl M, Treister R, Oaklander AL. Specific symptoms may discriminate
between fibromyalgia patients with vs without objective test evidence of small-
fiber polyneuropathy. PAIN Reports. 2017;3:1.
IF=N/A
35. Haddad M, Pud D, Treister R, Suzan E, Eisenberg E. The effects of a dopamine
agonist (apomorphine) on experimental and spontaneous pain in patients with
chronic radicular pain: A randomized, double-blind, placebo-controlled, cross-
over study. PLoS One. 2018;13:e0195287.
IF 2017= 2.766; R 2017= Multidisciplinary Sciences: 15/64 (Q1)
36. Liu X, Treister R, Lang M, Oaklander AL. IVIg for apparently autoimmune
small-fiber polyneuropathy: First analysis of efficacy and safety. Therapeutic
Advances in Neurological Disorders. 2018;11:175628561774448.
IF 2017= 4.750; R 2017= Clinical Neurology: 28/197 (Q1)
37. Grinstein A, Treister R. The unhappy postdoc: A survey based study.
F1000Research 2018;6:1642.
IF=N/A; SJR 2017= 0.926; R 2017= Biochemistry, Genetics and Molecular
Biology (miscellaneous): 62/243 (Q2); Immunology and Microbiology
(miscellaneous): 21/50 (Q2); Medicine (miscellaneous): 664/2863 (Q1);
Pharmacology, Toxicology and Pharmaceutics (miscellaneous): 11/111 (Q1)
38. Treister R, Lawal OD, Shecter JD, Khurana N, Bothmer J, Field M, Harte SE,
Kruger GH, Katz NP. Accurate pain reporting training diminishes the placebo
response: Results from a randomized, double-blind, crossover trial. PLoS One.
2018;13:e0197844.
IF 2017= 2.766; R 2017= Multidisciplinary Sciences: 15/64 (Q1)
39. Treister R, Suzan E, Lawal OD, Katz NP. Staircase-evoked Pain may be More
Sensitive than Traditional Pain Assessments in Discriminating Analgesic
Effects: A Randomized, Placebo-controlled Trial of Naproxen in Patients with
Osteoarthritis of the Knee. Clinical Journal of Pain. 2018 [Epub ahead of print].
IF 2017= 3.209; R 2017= Anesthesiology: 11/31 (Q2); Clinical Neurology:
69/197 (Q2)
Accepted for Publication
24
1. Arsenault P, Chiche D, Brown W, Miller J, Treister R, Leff R, Walker P, Katz
NP. NEO6860, Modality-Selective TRPV1 Antagonist: a Randomized,
Controlled, Proof-of-concept Trial in Patients with Osteoarthritis Knee Pain.
PAIN Reports 2018.
IF=N/A
E. Articles or Chapters in Scientific Books (Refereed)
Published
None
Accepted for Publication None
F. Articles in Conference Proceedings
Published
None
Accepted for Publication None
G. Entries in Encyclopedias
None
H. Other Scientific Publications
Published None
Accepted for Publication None
I. Other Works and Publications None
J. Submitted Publications Articles in Refereed Journals
1. Treister R, Honigman L, lawal O, Lanier RK, Katz NP. A deeper look at pain
variability and its relationship with the placebo response: results from a
randomized, double-blind, placebo-controlled clinical trial of naproxen in
osteoarthritis of the knee. Pain (under revision).
IF 2017= 5.559; R 2017= Anesthesiology: 3/31 (Q1); Clinical Neurology:
21/197 (Q1); Neurosciences: 35/261 (Q1)
25
2. Agostinho M, Canaipa R, Honigman L, Treister R. Relationships between the
ability to accurately report pain and accuracy reporting of other bodily
sensations. The Journal of Pain Research.
IF 2015= 2.363; R 2015= Clinical Neurology: 94/193 (Q2)
26
K. Summary of my Activities and Future Plans
I was fortunate to spend the past decade and a half in multiple pain clinics and
laboratories, and to be mentored by world-renowned experts in the field of pain
medicine and research. My early steps in the field of pain research began in 2005 at the
Institute for Pain Medicine at Rambam Health Care Campus, under the supervision of
Prof. Elon Eisenberg and Prof. Pud Dorit. During my graduate studies I focused on
investigating the effects of genetic factors and personality traits on pain sensitivity. Our
findings highlighted the mostly unexplored role of Dopamine in pain processing. This
topic later became the focus of my research during my first post-doc position under the
supervision of Prof. Dorit Pud at the Human Experimental Pain Research Laboratory, at
the University of Haifa. This productive period, during which we published more than
10 manuscripts, provided me with a solid foundation and expertise in various aspects of
clinical pain research.
In February 2013 we moved to Boston MA, to begin my second postdoctoral
position at the Harvard Medical School and Massachusetts General Hospital. I served
this period at the Nerve Injury Unit, under the supervision of Dr. Anne Louise
Oaklander. During my time there, I focused on two main research domains. The first
was the use of non-invasive brain stimulation for pain, including the use of state-of-the-
art neuro-navigated transcrainial magnetic stimulation (TMS) and transcranial direct-
current stimulation (tDSC) on neuropathic pain patients. The other domain was the
assessment and diagnosis of idiopathic small fiber polyneuropathy, a painful condition
that is often difficult to assess, diagnose and treat. Alongside with Prof. Oaklander and
others, we developed tools to assess, identify causes and treat SFPN. I am still working
closely with Dr. Oaklander and her collaborators on various clinical projects, and since
2013 we published 10 manuscripts together.
Alongside my academic activity, I served as the director of Research and
Development at Analgesic Solution (Natick, MA), a clinical reteach organization which
focus on consulting and performing analgesic drug development studies. I worked
closely with the owner and CEO of the organization, Dr. Nethaniel Katz, a former chair
of the Advisory Committee, Anesthesia, Critical Care and Addiction Products Division
of the U.S. Food and Drug Administration. In the field of pain research, as in other
clinical domains, experts agree that in negative clinical trials, it is often not that the
treatment is not effective, rather that factors relates to design, assessment and conduct of
27
the trial contribute to the failure. My main role and responsibility in Analgesic Solution
was to identify factors contributing to the low assay sensitivity of failed analgesic trails,
and figuring-out, developing and validating solutions that would improve the success of
future studies. I had a unique and privileged access to data of completed large-scale
pharma-sponsored multicenter studies and to work with leading experts from both
academia and industry, to analyze the data and identify factors contributing to the low
assay sensitivity of such trials. Thanks to this experience, a main focus of my current
and future research became the development and validation of methods aimed to
improve pain assessment. This focus of my research initiates my recent participation in
various forums such as the Analgesic, Anesthetic, and Addiction Clinical Trial
Translations, Innovations, Opportunities, and Networks (ACTTION), public-private
partnership with the United States Food and Drug Administration (FDA)
(http://www.acttion.org/). Since joining Analgesic Solutions, we published 5
manuscripts, focusing on the development and validation of improved pain, and pain-
related measures.
In October 2016, after 3 and half years in the US, my family and I returned to Israel,
where I began my new role as a faculty member in the Department of Nursing, at the
University of Haifa. Here, I established the Clinical Pain Innovation Lab, in which we
are preforming pain related projects involving various aspects of clinical pain
investigation, including the development of new methodologies to assess pain, assessing
the efficacy of various interventions, and studying pain-related underlying mechanisms.
I endeavor in these projects both independently and with collaborators from Israel and
abroad. Currently, the laboratory team is comprised 11 members, including a lab
manager (Dr. Liat Honigman), graduate students and research assistants. My goal is to
continue to develop and grow our research activities, with the ultimate goal of
generating new knowledge, tools and methods that will promote better pain assessment
and treatment. Being able to educate the future generation of nurses and to expose them
to recent topics in pain assessment and research also contribute to my main goal, by
expediting the process of dissemination of new knowledge, which will improve clinical
care and reduce pain and suffering of patients.
![MKG - By Treister [ENG] - Oral Chronic GVHD - PPT](https://img.pdfslide.net/doc/110x75/5695cf301a28ab9b028cfad1/mkg-by-treister-eng-oral-chronic-gvhd-ppt.jpg)
